Get the Stockscreener App
50.31
1.99%
-1.02
Eton Pharmaceuticals Inc stock is traded at $50.31, with a volume of 463.23K.
It is down -1.99% in the last 24 hours and down -10.72% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$51.33
Open:
$51.35
24h Volume:
463.23K
Relative Volume:
0.94
Market Cap:
$1.44B
Revenue:
$86.93M
Net Income/Loss:
$-1.48M
P/E Ratio:
-709.59
EPS:
-0.0709
Net Cash Flow:
$431.00K
1W Performance:
-8.88%
1M Performance:
-10.72%
6M Performance:
+105.94%
1Y Performance:
+174.32%
1-Day Range:
$49.07
$51.87
1-Week Range:
$49.07
$57.00
52-Week Range:
$14.27
$66.37
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
50.31 | 1.44B | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-26 | Initiated | Canaccord Genuity | Buy |
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com Nigeria
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com South Africa
Eton Pharmaceuticals CBO David Krempa sells $229k in stock By Investing.com - Investing.com South Africa
Eton Pharmaceuticals CBO David Krempa sells $229k in stock - Investing.com
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com Australia
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com UK
ETON Stock Surges 108% in Six Months: Here's What You Need to Know - Zacks Investment Research
To cover stock-grant vesting, Eton Pharmaceuticals (ETON) officer proposes selling 4,166 shares. - Stock Titan
ETON Stock Rises as Eton Pharmaceuticals Secures Impavido Rights - timothysykes.com
Eton Pharmaceuticals (ETON) Slides 9.55% to $53.54 as Shares Retreat Toward SupportValue Factor - dars.gov.et
Bank of America Corp DE Acquires New Shares in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Form 8K Eton Pharmaceuticals Inc For: 28 September By Investing.com - Investing.com Nigeria
Form 8K Eton Pharmaceuticals Inc For: 28 September By Investing.com - Investing.com Canada
Neurogene Inc. (NGNE) Stock Price & News - Syfe
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9%Should You Buy? - MarketBeat
Eton Pharmaceuticals (NasdaqGM:ETON) Stock Forecast & Analyst Predictions - Simply Wall Street
Eton Pharmaceutcials (ETON) Stock Price, News & Analysis - Stock Titan
Eton Pharmaceuticals stock holds steady as insider sales and recent results shape the picture - AD HOC NEWS
Eton Pharmaceuticals stock holds steady as investors eye latest results - AD HOC NEWS
HighTower Advisors LLC Acquires 34,484 Shares of Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Hsbc Holdings PLC Makes New $1.53 Million Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Nuvectis Pharma, Inc. (NVCT) Stock Price & News - Syfe
Eton Pharmaceuticals (ETON) Heads To Wells Fargo Conference As Fair Value Debate Stays Open - simplywall.st
118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp - MarketBeat
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
ETON stock holds firm after latest quarter shows steady growth - AD HOC NEWS
Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M - Benzinga
Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Director Paul V. Maier Executes Stock Options and Sells Shares on August 28, 2026 - Kalkine Media
Eton Pharmaceuticals (ETON) director unloads 50K shares after option exercise - Stock Titan
34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc. - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON - MarketBeat
BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Slips 1.74% as Shares Pull Back Toward Key SupportPrice Action Signals - dars.gov.et
Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE - MarketBeat
1,175,951 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Nantahala Capital Management LLC - MarketBeat
Cannell Capital LLC Acquires New Stake in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Director Sells $2,953,500.00 in Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ: ETON) insider sells 50K shares - Stock Titan
Bank of Nova Scotia Acquires New Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Insider Sold Shares Worth $2,953,572, According to a Recent SEC Filing - Yahoo Finance
Eton Pharmaceuticals (NASDAQ:ETON) Shares Down 4.4%Here's Why - MarketBeat
Eton leaders will hold one-on-one meetings at Wells Fargo’s Boston event - stocktitan.net
Pillsbury Lake Capital LLC Invests $14.02 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield' - sahmcapital.com
Eton's Galzin TM And False Ad Suit Survives Dismissal Bid - Law360
Eton Pharmaceuticals Can Proceed With ‘Gluzin’ Supplement Suit - Bloomberg Law News
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Eton Pharmaceuticals Inc Stock (ETON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Krempa David | Officer |
Oct 06 '26 |
Proposed Sale |
55.07 |
4,166 |
229,406 |
0 |
| MAIER PAUL V | Director |
Aug 28 '26 |
Option Exercise |
3.78 |
50,000 |
189,000 |
109,745 |
| MAIER PAUL V | Director |
Aug 28 '26 |
Sale |
59.07 |
50,000 |
2,953,572 |
59,745 |
| MAIER PAUL V | Director |
Aug 28 '26 |
Proposed Sale |
59.07 |
50,000 |
2,953,530 |
0 |
| Krempa David | Officer |
Aug 24 '26 |
Proposed Sale |
65.07 |
25,000 |
1,626,750 |
0 |
| Krempa David | Chief Business Officer |
Aug 24 '26 |
Sale |
65.07 |
25,000 |
1,626,750 |
37,025 |
| Krempa David | Chief Business Officer |
Aug 24 '26 |
Option Exercise |
7.31 |
25,000 |
182,750 |
62,025 |
| BRYNJELSEN SEAN | President & CEO |
Aug 20 '26 |
Sale |
60.70 |
91,022 |
5,525,301 |
961,194 |
| BRYNJELSEN SEAN | Director |
Aug 19 '26 |
Proposed Sale |
63.43 |
100,000 |
6,343,000 |
0 |
| BRYNJELSEN SEAN | President & CEO |
Aug 19 '26 |
Sale |
62.65 |
8,978 |
562,472 |
1,052,216 |
0.03%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):